Sustainable Child-Safe Packaging

Claim My Business
Min Investment
Boulder, CO
Offering Date
December 05, 2022
Expected Close Date
February 03, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

Founded in 2016 in Boulder, Colorado, Mediloq, Inc. pioneered durable, ruggedized, child-safe containers for the B2C outdoor recreational market, generating hundreds of thousands in revenue. We are now leveraging our IP and traction, raising funds to develop a B2B sustainable child-safe packaging business, which will offer pharmaceutical, supplement, cannabis, and household cleaner brands a sustainable alternative to plastic packaging.

Key Deal Facts

RIGHT MARKET TIMING: With plastic pollution becoming one of the largest public health threats, 200 countries and the state of California have recently agreed to ban plastic packaging, and we are one of the few companies positioned to meet the growing demand for sustainable alternatives.*

NARROW NICHE IN A HUGE MARKET: The Global Sustainable Packaging Market was valued at $265.9 Billion in 2021. We are focusing on the Sustainable Child-Safe Packaging market, which is projected to reach a global market size of $27.1 Billion by 2027. We believe our IP, proven design, and traction give us an advantage in this evolving market, and we currently have 2 filed patents to protect our unique child-safe packaging from competitors in the market.**

EARLY TRACTION: Mediloq previously raised $36.8k on Ignite Social Impact. Our related retail brands (Canniloq, Corloq, and Coffeeloq) have already generated hundreds of thousands in revenue, and we recently partnered with a firm to sell one of our B2C brands in up to 900+ B&M stores across the US. Additionally, our team is highly experienced, including Chief Pharmaceutical Advisor Dr. Sabine Kapasi. As a UN strategy lead and supply chain head at Doctors Without Borders, she is an eminent authority on the global medication supply chain and is facilitating discussions between Mediloq and several potential pharmaceutical partners.

Management Team / Advisory Board Bios

Dan EstoqueCEODan is a gifted business visionary strategist with a tenacious, disciplined work ethic. He has a proven track record of conceiving, planning and executing projects during his 25 year career of helping entrepreneurs, startups and large corporations bring products to market. He has been involved in several startup ventures, and holds 6 revenue-generating patents. He works for the company 30 hours a week., Henry Burgess-MarshallDirector of MarketingHenry is a creative, high-energy, marketing professional with an entrepreneurial drive, and was responsible for creating and accelerating the company’s retail marketing strategy and brand recognition on a national level. His previous achievements include increasing revenue 10X for an entertainment business, and he spends countless hours volunteering. He works for the company 2 hours a week.
Nick LegareDirector of SalesNick has 12+ years as an accomplished sales leader with a passion for growing start-up brands. He is specialized in strategic development and implementation of short and long-term sales plans including product direction, consumer segmentation, market opportunities, growth expectations, and budget management. He works for the company 2 hours a week.

Dr. Sabine KapasiChief Pharmaceutical AdvisorDr. Kapasi is a health policy and governance strategy lead, currently working as UN strategy lead on the global COVID 19 task force. She is governance strategy lead and supply chain procurement head at Médecins Sans Frontières UN, advises the governments of 11 states on health policy, and studied at The Wharton School, Harvard Business School and NYU Stern School of Business. She works for the company 2 hours a week.

Ted Agne Chief Life Science AdvisorTed Agne is a corporate communications executive in the areas of biotechnology, healthcare, and life sciences. He has served as an advisor and director for organizations including: Oxford Bioscience Network, One Nucleus, The Forsyth Institute biomedical research organization, the Global Federation of Competitiveness Councils, and Trifermed. He works for the company 2 hours a week.,
Amount Raised : $13,125
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Research Reports

No reports have been submitted

Become a Reporter